−£280k
vs Dec 2024Active11628210Private limited companyCroydon
FARMAKO LIMITED
Significant control: Medifast Gmbh (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Farmako Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
FARMAKO LIMITED is an active private limited company (company number 11628210) incorporated on 17 October 2018, registered in Croydon. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 31 December 2025, showing net assets of −£280k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 22% on the prior period (−£228k). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the bottom quarter of 319 comparable companies in Greater London (median £6,251, upper quartile £199k).
02
Ownership and control
- Medifast Gmbh
- owns 75–100% of shares
- holds 75–100% of voting rights
- Farmako Gmbh
- has significant influence or control
- Mr Sebastian Diemer
- has significant influence or control
- Mr Niklas Alexander Kouparanis
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
- Mr. Konstantinos Primbas
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 October 20188 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 31 October 2026in 8 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£280k | — | — | — | — | — | 1 |
| 31 December 2024 | −£228k | — | — | — | — | — | 1 |
| 31 December 2023 | −£160k | — | — | — | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-279,515 at 31 December 2025
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 17 October 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 8 days
- Accounts period endNet liabilities £280k · micro accounts
- Accounts period endNet liabilities £228k · micro accounts
- Accounts period endNet liabilities £160k · micro accounts
- Incorporated
08
Similar companies in Greater London
- CELLCHEM UK LIMITEDSouthall · inc. Nov 2018
- CELLTRION HEALTHCARE UNITED KINGDOM LIMITEDUxbridge · inc. Nov 2018
- VALUGEN PHARMA LIMITEDHarrow · inc. Nov 2018
- GLOBAL SCS LIMITEDRuislip · inc. Sept 2018
- RAPID PHARMA LIMITEDWatford · inc. Dec 2018
- SPECIALS PHARMA LTDDagenham · inc. Dec 2018
All companies incorporated on 17 October 2018 · in Oct 2018.
09
Reminders for FARMAKO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.